Oral Application Of Bacterial Lysate In Infancy Decreases The Risk Of Infantile Atopic Eczema In A Subgroup Of Children With Paternal Atopy
In a double-blind placebo-controlled trial, 553 healthy infants with at least single positive heredity for atopy were treated daily from week 5 until the end of month 7 by oral route with bacterial lysate (Pro-Symbioflor) containing heat-killed gram-negative E. coli and grampositive Enterococcus fae...
Gespeichert in:
| Veröffentlicht in: | Journal of allergy and clinical immunology 2011-02, Vol.127 (2), p.AB34-AB34 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | AB34 |
|---|---|
| container_issue | 2 |
| container_start_page | AB34 |
| container_title | Journal of allergy and clinical immunology |
| container_volume | 127 |
| creator | Lau, S.G Gerhold, K Sulser, C Rossberg, S Witt, I Wauer, J Beschorner, J Bunikowski, R Zimmermann, K Menke, G Wahn, U |
| description | In a double-blind placebo-controlled trial, 553 healthy infants with at least single positive heredity for atopy were treated daily from week 5 until the end of month 7 by oral route with bacterial lysate (Pro-Symbioflor) containing heat-killed gram-negative E. coli and grampositive Enterococcus faecalis (1.5-4.5 x 107 bacteria/ml). |
| doi_str_mv | 10.1016/j.jaci.2010.12.146 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1550203019</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0091674910020877</els_id><sourcerecordid>3390065211</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2726-5bd07fee7622f8ff1f0def88d52fc9c6e422a5d883d8f8b2bab33a8d84d5bb803</originalsourceid><addsrcrecordid>eNp9kV9r2zAUxcVYoVnbL9AnwZ6dSXJsyzAGWdZ_EEhpO_YoZOlqkePYnmQX3K_QL12pKRT6MBAI6Z7f5XAOQueUzCmh-bd6Xktl54zEDzani_wTmlFSFknOWfYZzQgpaZIXi_IYffG-JuGd8nKGnjdONnjZ941VcrBdizcG_5RqAGfDYD15OQC-acMxslUT_gXKgfTg8cMW8J31u0i8TgfbAF4OXW8VvlBPsJcRXOL7sfrrurGPwtXWNtpBi__YYYtvw3LXRgOBmk7RkZGNh7O3-wT9vrx4WF0n683VzWq5ThQrWJ5klSaFAShyxgw3hhqiwXCuM2ZUqXJYMCYzzXmqueEVq2SVppJrvtBZVXGSnqCvh7296_6N4AdRd2O04QXNMsJISmgZVOygUq7z3oERvbN76SZBiYihi1rE0EUMXVAmQugB-n6AIPh_tOCEVxZaBdo6UIPQnf0__uMDrhrbhmaaHUzg320KzwQR97HVWColwTUvivQF_gmf8w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1550203019</pqid></control><display><type>article</type><title>Oral Application Of Bacterial Lysate In Infancy Decreases The Risk Of Infantile Atopic Eczema In A Subgroup Of Children With Paternal Atopy</title><source>ScienceDirect Journals (5 years ago - present)</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Lau, S.G ; Gerhold, K ; Sulser, C ; Rossberg, S ; Witt, I ; Wauer, J ; Beschorner, J ; Bunikowski, R ; Zimmermann, K ; Menke, G ; Wahn, U</creator><creatorcontrib>Lau, S.G ; Gerhold, K ; Sulser, C ; Rossberg, S ; Witt, I ; Wauer, J ; Beschorner, J ; Bunikowski, R ; Zimmermann, K ; Menke, G ; Wahn, U</creatorcontrib><description>In a double-blind placebo-controlled trial, 553 healthy infants with at least single positive heredity for atopy were treated daily from week 5 until the end of month 7 by oral route with bacterial lysate (Pro-Symbioflor) containing heat-killed gram-negative E. coli and grampositive Enterococcus faecalis (1.5-4.5 x 107 bacteria/ml).</description><identifier>ISSN: 0091-6749</identifier><identifier>EISSN: 1097-6825</identifier><identifier>DOI: 10.1016/j.jaci.2010.12.146</identifier><language>eng</language><publisher>St. Louis: Mosby, Inc</publisher><subject>Allergy and Immunology ; Children & youth ; Eczema</subject><ispartof>Journal of allergy and clinical immunology, 2011-02, Vol.127 (2), p.AB34-AB34</ispartof><rights>2011</rights><rights>Copyright Elsevier Limited Feb 2011</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2726-5bd07fee7622f8ff1f0def88d52fc9c6e422a5d883d8f8b2bab33a8d84d5bb803</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jaci.2010.12.146$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27922,27923,45993</link.rule.ids></links><search><creatorcontrib>Lau, S.G</creatorcontrib><creatorcontrib>Gerhold, K</creatorcontrib><creatorcontrib>Sulser, C</creatorcontrib><creatorcontrib>Rossberg, S</creatorcontrib><creatorcontrib>Witt, I</creatorcontrib><creatorcontrib>Wauer, J</creatorcontrib><creatorcontrib>Beschorner, J</creatorcontrib><creatorcontrib>Bunikowski, R</creatorcontrib><creatorcontrib>Zimmermann, K</creatorcontrib><creatorcontrib>Menke, G</creatorcontrib><creatorcontrib>Wahn, U</creatorcontrib><title>Oral Application Of Bacterial Lysate In Infancy Decreases The Risk Of Infantile Atopic Eczema In A Subgroup Of Children With Paternal Atopy</title><title>Journal of allergy and clinical immunology</title><description>In a double-blind placebo-controlled trial, 553 healthy infants with at least single positive heredity for atopy were treated daily from week 5 until the end of month 7 by oral route with bacterial lysate (Pro-Symbioflor) containing heat-killed gram-negative E. coli and grampositive Enterococcus faecalis (1.5-4.5 x 107 bacteria/ml).</description><subject>Allergy and Immunology</subject><subject>Children & youth</subject><subject>Eczema</subject><issn>0091-6749</issn><issn>1097-6825</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNp9kV9r2zAUxcVYoVnbL9AnwZ6dSXJsyzAGWdZ_EEhpO_YoZOlqkePYnmQX3K_QL12pKRT6MBAI6Z7f5XAOQueUzCmh-bd6Xktl54zEDzani_wTmlFSFknOWfYZzQgpaZIXi_IYffG-JuGd8nKGnjdONnjZ941VcrBdizcG_5RqAGfDYD15OQC-acMxslUT_gXKgfTg8cMW8J31u0i8TgfbAF4OXW8VvlBPsJcRXOL7sfrrurGPwtXWNtpBi__YYYtvw3LXRgOBmk7RkZGNh7O3-wT9vrx4WF0n683VzWq5ThQrWJ5klSaFAShyxgw3hhqiwXCuM2ZUqXJYMCYzzXmqueEVq2SVppJrvtBZVXGSnqCvh7296_6N4AdRd2O04QXNMsJISmgZVOygUq7z3oERvbN76SZBiYihi1rE0EUMXVAmQugB-n6AIPh_tOCEVxZaBdo6UIPQnf0__uMDrhrbhmaaHUzg320KzwQR97HVWColwTUvivQF_gmf8w</recordid><startdate>20110201</startdate><enddate>20110201</enddate><creator>Lau, S.G</creator><creator>Gerhold, K</creator><creator>Sulser, C</creator><creator>Rossberg, S</creator><creator>Witt, I</creator><creator>Wauer, J</creator><creator>Beschorner, J</creator><creator>Bunikowski, R</creator><creator>Zimmermann, K</creator><creator>Menke, G</creator><creator>Wahn, U</creator><general>Mosby, Inc</general><general>Elsevier Limited</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7SS</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20110201</creationdate><title>Oral Application Of Bacterial Lysate In Infancy Decreases The Risk Of Infantile Atopic Eczema In A Subgroup Of Children With Paternal Atopy</title><author>Lau, S.G ; Gerhold, K ; Sulser, C ; Rossberg, S ; Witt, I ; Wauer, J ; Beschorner, J ; Bunikowski, R ; Zimmermann, K ; Menke, G ; Wahn, U</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2726-5bd07fee7622f8ff1f0def88d52fc9c6e422a5d883d8f8b2bab33a8d84d5bb803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Allergy and Immunology</topic><topic>Children & youth</topic><topic>Eczema</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lau, S.G</creatorcontrib><creatorcontrib>Gerhold, K</creatorcontrib><creatorcontrib>Sulser, C</creatorcontrib><creatorcontrib>Rossberg, S</creatorcontrib><creatorcontrib>Witt, I</creatorcontrib><creatorcontrib>Wauer, J</creatorcontrib><creatorcontrib>Beschorner, J</creatorcontrib><creatorcontrib>Bunikowski, R</creatorcontrib><creatorcontrib>Zimmermann, K</creatorcontrib><creatorcontrib>Menke, G</creatorcontrib><creatorcontrib>Wahn, U</creatorcontrib><collection>CrossRef</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><jtitle>Journal of allergy and clinical immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lau, S.G</au><au>Gerhold, K</au><au>Sulser, C</au><au>Rossberg, S</au><au>Witt, I</au><au>Wauer, J</au><au>Beschorner, J</au><au>Bunikowski, R</au><au>Zimmermann, K</au><au>Menke, G</au><au>Wahn, U</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Oral Application Of Bacterial Lysate In Infancy Decreases The Risk Of Infantile Atopic Eczema In A Subgroup Of Children With Paternal Atopy</atitle><jtitle>Journal of allergy and clinical immunology</jtitle><date>2011-02-01</date><risdate>2011</risdate><volume>127</volume><issue>2</issue><spage>AB34</spage><epage>AB34</epage><pages>AB34-AB34</pages><issn>0091-6749</issn><eissn>1097-6825</eissn><abstract>In a double-blind placebo-controlled trial, 553 healthy infants with at least single positive heredity for atopy were treated daily from week 5 until the end of month 7 by oral route with bacterial lysate (Pro-Symbioflor) containing heat-killed gram-negative E. coli and grampositive Enterococcus faecalis (1.5-4.5 x 107 bacteria/ml).</abstract><cop>St. Louis</cop><pub>Mosby, Inc</pub><doi>10.1016/j.jaci.2010.12.146</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0091-6749 |
| ispartof | Journal of allergy and clinical immunology, 2011-02, Vol.127 (2), p.AB34-AB34 |
| issn | 0091-6749 1097-6825 |
| language | eng |
| recordid | cdi_proquest_journals_1550203019 |
| source | ScienceDirect Journals (5 years ago - present); EZB-FREE-00999 freely available EZB journals |
| subjects | Allergy and Immunology Children & youth Eczema |
| title | Oral Application Of Bacterial Lysate In Infancy Decreases The Risk Of Infantile Atopic Eczema In A Subgroup Of Children With Paternal Atopy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T22%3A56%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Oral%20Application%20Of%20Bacterial%20Lysate%20In%20Infancy%20Decreases%20The%20Risk%20Of%20Infantile%20Atopic%20Eczema%20In%20A%20Subgroup%20Of%20Children%20With%20Paternal%20Atopy&rft.jtitle=Journal%20of%20allergy%20and%20clinical%20immunology&rft.au=Lau,%20S.G&rft.date=2011-02-01&rft.volume=127&rft.issue=2&rft.spage=AB34&rft.epage=AB34&rft.pages=AB34-AB34&rft.issn=0091-6749&rft.eissn=1097-6825&rft_id=info:doi/10.1016/j.jaci.2010.12.146&rft_dat=%3Cproquest_cross%3E3390065211%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1550203019&rft_id=info:pmid/&rft_els_id=1_s2_0_S0091674910020877&rfr_iscdi=true |